Terns Pharmaceuticals (TERN) Other Non Operating Income: 2020-2024
Historic Other Non Operating Income for Terns Pharmaceuticals (TERN) over the last 5 years, with Dec 2024 value amounting to -$11,000.
- Terns Pharmaceuticals' Other Non Operating Income fell 140.00% to -$4,000 in Q4 2022 from the same period last year, while for Dec 2022 it was -$68,000, marking a year-over-year decrease of 270.00%. This contributed to the annual value of -$11,000 for FY2024, which is 96.50% up from last year.
- Per Terns Pharmaceuticals' latest filing, its Other Non Operating Income stood at -$11,000 for FY2024, which was up 96.50% from -$314,000 recorded in FY2023.
- Terns Pharmaceuticals' 5-year Other Non Operating Income high stood at $10.7 million for FY2020, and its period low was -$314,000 during FY2023.
- In the last 3 years, Terns Pharmaceuticals' Other Non Operating Income had a median value of -$68,000 in 2022 and averaged -$131,000.
- In the last 5 years, Terns Pharmaceuticals' Other Non Operating Income tumbled by 361.76% in 2023 and then surged by 96.50% in 2024.
- Terns Pharmaceuticals' Other Non Operating Income (Yearly) stood at $10.7 million in 2020, then crashed by 99.63% to $40,000 in 2021, then tumbled by 270.00% to -$68,000 in 2022, then slumped by 361.76% to -$314,000 in 2023, then soared by 96.50% to -$11,000 in 2024.